Companies › PAVM

PAVmed Inc (PAVM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001624326 · EDGAR filings · Updated 2026-06-24

PAVmed Inc (PAVM) has reported institutional ownership of 8.0%, with 20 institutional managers holding positions valued at $5.20M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-06-24 — Current report (8-K) filed
• 2026-05-15 — SCHEDULE 13G filed
• 2026-05-15 — Current report (8-K) filed
• 2026-05-14 — Quarterly report (10-Q) filed
• 2026-05-14 — SCHEDULE 13G filed
• 2026-05-11 — SCHEDULE 13G/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PAVmed Inc has 20 institutional holders and institutional ownership of 8.0%.

Insider activity

Insiders reported 9 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

ESTRELLA IMMUNOPHARMA INC (ESLA) · ACTINIUM PHARMACEUTICALS INC (ATNM) · Lisata Therapeutics Inc (LSTA) · MINDWALK HOLDINGS CORP COM (HYFT) · Marker Therapeutics Inc (MRKR) · CUE BIOPHARMA (CUE)